Rayaldee is now approved! Visit the new Rayaldee Web Site  

Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism


Recent News:

RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
February 3, 2022

OPKO Health Announces Topline Results from Phase 2 Trial Evaluating RAYALDEE to Treat Symptomatic COVID-19 Outpatients
December 23, 2021

OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients
August 30, 2021




© 2022 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use